Sharon Bradni, NP
Critical Care Medicine · Fresno, CANPI 1902314933
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,537 of the $9,765 with a category attached, or 87.4%. It is spread thinly across 41 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Among critical care medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $48.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- AbbVie$1K
- UCB, Inc.$629
- Amgen$369
- plus $4K from 35 others
What the payments were for
- Travel & lodging$1,00710%
- Food & beverage$8,53787%
- Education$2212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,410 |
| Teva Pharmaceuticals USA, Inc. | 33 | $1,213 |
| Neurocrine Biosciences, Inc. | 31 | $1,088 |
| AbbVie | 28 | $1,055 |
| UCB, Inc. | 13 | $629 |
| Amgen | 3 | $369 |
| Acadia Pharmaceuticals Inc | 2 | $302 |
| Otsuka America Pharmaceutical, Inc. | 5 | $297 |
| SK Life Science, Inc. | 7 | $291 |
| Pfizer | 12 | $286 |
| GSK | 2 | $222 |
| Axsome Therapeutics, Inc. | 5 | $218 |
| Medtronic | 4 | $218 |
| AstraZeneca | 5 | $200 |
| Saluda Medical Americas, Inc. | 5 | $163 |
| Nevro Corp. | 2 | $162 |
| Eisai Inc. | 2 | $150 |
| Amneal Pharmaceuticals LLC | 2 | $148 |
| Novo Nordisk | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $124 |
| Dynavax Technologies Corporation | 1 | $117 |
| Chiesi USA, Inc. | 1 | $110 |
| Abiomed | 1 | $101 |
| Biogen | 4 | $97 |
| Lundbeck LLC | 3 | $54 |
| Octapharma USA, Inc. | 1 | $52 |
| Tanabe Pharma America, Inc. | 2 | $49 |
| Esperion Therapeutics, Inc. | 1 | $49 |
| Neurelis, Inc. | 2 | $48 |
| CSL Behring | 2 | $44 |
| Johnson & Johnson | 1 | $33 |
| Globus Medical | 2 | $29 |
| Caris MPI, Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $24 |
| Acorda Therapeutics, Inc | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Novocure Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,765 in reported general payments places this provider in the 90th percentile of 715 critical care medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 106 | $4,942 |
| Memantine Hcl | 47 | $2,272 |
| AmantadineAmantadine Hcl | 50 | $1,960 |
| Levetiracetam | 24 | $1,672 |
| Gabapentin | 54 | $1,073 |
| Oxcarbazepine | 13 | $1,053 |
| Donepezil Hcl | 68 | $806 |
| Primidone | 16 | $592 |
| Topiramate | 12 | $299 |
| Pregabalin | 19 | $250 |
| Duloxetine Hcl | 17 | $144 |
| Escitalopram Oxalate | 14 | $94 |
| Naproxen | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Fresno
- Pankaj BharatiFresno$12K
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
- Stephen ChenMonterey Park$394K
- Bassam YaghmourOrange$376K
- Xuanha WhiteSan Diego$343K
- Ken YonedaSacramento$173K
- Praveen AkuthotaSan Diego$169K
- Ivan ChengSan Francisco$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.